Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001306142 | SCV001495501 | uncertain significance | Cohen syndrome | 2021-09-01 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001306142 | SCV002082646 | uncertain significance | Cohen syndrome | 2021-07-16 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004743392 | SCV005341576 | uncertain significance | VPS13B-related disorder | 2024-02-26 | no assertion criteria provided | clinical testing | The VPS13B c.7301C>T variant is predicted to result in the amino acid substitution p.Thr2434Ile. To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |